Developer docs
API playgroundTry for free, no card

Search company profiles

JN Medsys

Full company profile

uuid000jl8d

Namestring
JN Medsys
Legal namestring
JN Medsys
Websiteurl
jnmedsys.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

JN Medsys is a privately held life science tools company headquartered in Singapore (with Beijing also cited as a founding location) that develops and commercializes a chip-based digital PCR (dPCR) platform under the Clarity product family. The company's core technology is a proprietary high-density chip-in-a-tube partitioning architecture that produces over 40,000 nanoliter partitions per reaction, combined with a 6-color CMOS detection platform that enables multiplexed absolute quantification of DNA and RNA without reference standards. The product ecosystem comprises the Clarity Plus Digital PCR System (Reader, Auto-Loader, Sealing Enhancer, software), the Exponent Thermal Cycler, chip-based consumables (40K and 10K tube-strips) that drive recurring revenue, and a portfolio of pre-formulated and custom assay kits.

JN Medsys monetizes through a hybrid model combining capital equipment sales, single-use consumables, assay kits, and fee-for-service laboratory offerings that include sample analysis, assay development, clinical validation via a Ministry of Health approved clinical laboratory, and NGS services. Go-to-market is executed through direct sales out of Singapore and a network of eight authorized regional distributors across China, Japan, South Korea, India, Taiwan, Vietnam, Indonesia, and Turkey, targeting research and academic institutions as well as clinical and diagnostics companies.

The company's differentiation rests on three pillars: a technically novel partitioning method that competes with Bio-Rad, Thermo Fisher, and Stilla on partition density and dynamic range; an AI-assisted analysis pipeline that automates positive/negative partition classification across tens of thousands of data points per run; and an explicit affordability positioning relative to incumbent dPCR platforms. Visible customers include the National University of Singapore, National Cheng Kung University, the Institute of Molecular and Cell Biology, Nippon Dental University, and DAAN GENE, and the company supports its commercial narrative through a library of peer-reviewed publications.

Short descriptiontext

JN Medsys is a Singapore-headquartered life science tools company that develops chip-based digital PCR instruments, consumables, assay kits, and laboratory services for absolute nucleic acid quantification, serving academic, clinical diagnostics, and industrial customers across Asia-Pacific via direct sales and eight regional distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Digital PCR instruments, Nucleic acid quantification, Molecular biology instruments, Genomics research tools, PCR consumables
Industry4 codes
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Laboratories621511
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Digital PCR Instrumentation
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Instruments and Hardware
TypeHardware Sales
Description

Sale of Clarity Plus Digital PCR system, Clarity Auto-Loader, Clarity Sealing Enhancer, Clarity Plus Reader, and related instrument components.

jnmedsys.com
2Consumables
TypeHardware Sales
Description

Sale of proprietary chip-based consumables including 40K and 10K tube-strips, sample loading kits, and sealing fluid. Recurring revenue from consumables as they are single-use per experiment.

jnmedsys.com
3Laboratory Services
TypeProfessional Services
Description

Fee-for-service laboratory analysis including digital PCR sample analysis, qPCR services, assay development and validation, clinical validation (Ministry of Health approved clinical laboratory), and next-generation sequencing (NGS) services.

jnmedsys.com
4Assay Kits
TypeOne Time License
Description

Sale of pre-developed and custom assay kits for specific molecular detection applications.

jnmedsys.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Clarity Plus Digital PCR System
ModelOtherBilling cadenceMulti-year contract
Notes

System components include Clarity Plus Reader, Auto-Loader, Sealing Enhancer, and software. Part of product catalog for enterprise/research customers.

jnmedsys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Clarity
Description

Digital PCR system product line

jnmedsys.com
+1 more record
Core offering1 text field

JN Medsys designs, manufactures, and sells high-density chip-based digital PCR (dPCR) systems for absolute quantification of nucleic acids (DNA and RNA). Its flagship Clarity Plus Digital PCR System provides over 40,000 partitions per reaction with 6-colour multiplex detection, complemented by proprietary 40K and 10K chip-in-a-tube consumables, the Exponent Thermal Cycler, assay kits, and fee-for-service laboratory work including sample analysis, assay development, clinical validation, and next-generation sequencing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 40,000 partitions per reaction for single molecule analysis providing higher sensitivity and better accuracy over wider dynamic range
+2 more records
Product overview1 text field

JN Medsys offers a comprehensive digital PCR ecosystem built around their proprietary high-density chip-based partitioning technology. The core offering consists of the Clarity Plus Digital PCR System (instrument with 6-color detection, up to 96 reactions, 40,000+ partitions per reaction), supported by dedicated Clarity Consumables (40K and 10K tube-strips with chip-in-a-tube design). The system is complemented by the Exponent Thermal Cycler and Assay Kits for complete workflow solutions. All components are designed to work together seamlessly, with automated sample loading via the Auto-Loader and AI-powered software for data analysis.

Product and service8 records
1Clarity Plus Digital PCR System
CategoryDigital PCR Instrument
Description

A cutting-edge digital PCR system featuring more than 40,000 partitions per reaction on a high-density chip, delivering high resolution, sensitivity, and dynamic range for RNA and DNA quantification. It includes a 6-colour detection platform for multiplexed quantification of up to 6 targets without reference standards, supports up to 96 reactions per run, and uses AI-powered software for absolute quantification. It is intended for research laboratories, clinical diagnostics developers, and applied testing organizations.

2Clarity Consumables (40K and 10K Tube-Strips)
CategoryDigital PCR Consumables
Description

Proprietary single-use chip-in-a-tube consumables for the Clarity / Clarity Plus digital PCR system, available in 40K (40,000-45,000 partitions, 0.3 nL per partition) and 10K (10,000 partitions, 1.3 nL per partition) formats. Each tube-strip holds 8 samples, and the chip design with excess capacity keeps sample loss below 5% while ensuring the entire sample volume is partitioned. Consumables generate recurring revenue for JN Medsys and are intended for any laboratory performing digital PCR experiments.

3Exponent Thermal Cycler
CategoryPCR Instrument
Description

A thermal cycler compatible with the Clarity Plus digital PCR system, used to perform PCR amplification of partitioned samples as part of the Clarity workflow. Sold to research and clinical laboratories using the JN Medsys digital PCR platform.

4Assay Kits
CategoryDigital PCR Consumables
Description

Pre-formulated and custom assay kits for digital PCR applications, including in-house assays and assays developed against customer specifications for specific research or clinical detection needs. Sold to research and clinical laboratory customers using the Clarity digital PCR platform.

5Sample Analysis Service
CategoryLaboratory Services
Description

Fee-for-service laboratory service in which JN Medsys receives customer samples and analyzes and quantifies them using in-house or customer-provided digital PCR and qPCR assays. Targeted at customers who need digital PCR data without running the workflow themselves.

6Assay Development Service
CategoryLaboratory Services
Description

Custom assay development service for digital PCR and qPCR, including validation and on-request manufacturing for the customer. Targeted at research and clinical diagnostics customers needing tailored molecular detection assays.

7Clinical Validation Service
CategoryLaboratory Services
Description

Clinical laboratory validation of customer diagnostic products for regulatory purposes, performed in JN Medsys' Ministry of Health-approved clinical laboratory. Targeted at diagnostics companies preparing products for regulatory submission.

8Next Generation Sequencing (NGS) Service
CategoryLaboratory Services
Description

Next-generation sequencing service run by JN Medsys as an offering for customers who require sequencing in addition to or instead of digital PCR. Targeted at the same research and clinical customers served by the Clarity digital PCR system.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Hangzhou Neoline Technology Co., Ltd.
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for China market covering Hangzhou region with responsibility for sales, support, and distribution of JN Medsys digital PCR products.

jnmedsys.com
2Restar Corporation
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Japan market providing local sales and distribution of Clarity digital PCR systems and consumables.

jnmedsys.com
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for South Korea market based in Gwangmyeong Technopark.

4Premas Life Sciences Pvt Ltd
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for India market based in New Delhi, providing distribution of JN Medsys products.

jnmedsys.com
5EYS Medikal ve Lab. Pro.
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Turkey market providing sales and distribution services.

jnmedsys.com
6Bestgen Biotech Corp.
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Taiwan market based in New Taipei City.

jnmedsys.com
7Suran Medical & Scientific Solution
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Vietnam market providing medical and scientific solutions.

jnmedsys.com
Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Indonesia market based in Jakarta.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Bio-Rad's QX200 and QX600 droplet digital PCR systems are the dominant installed-base competitor to JN Medsys's Clarity Plus, serving similar academic, clinical, and applied-market customers with chip-equivalent partitioning and multiplex workflows.

TypeDirect peer
Description

QIAGEN's QIAcuity nanoplates-based dPCR platform competes head-to-head with Clarity Plus in research and clinical labs, offering higher-throughput plates, an IVD-cleared kitted assay menu, and global commercial reach that JN Medsys lacks.

TypeBroad incumbent
Description

Thermo Fisher's QuantStudio Absolute Q digital PCR system, sold alongside its broader qPCR, NGS, and clinical diagnostics portfolios, overlaps directly with JN Medsys's instrument and consumables offering while leveraging unmatched global service and support infrastructure.

TypeDirect peer
Description

Stilla's Naica crystal digital PCR system uses similar chip-based partitioning and 6-color multiplex chemistry to Clarity Plus, targeting rare-mutation, liquid-biopsy, and oncology research customers across Europe and North America.

TypeBroad incumbent
Description

Roche's LightCycler and digital PCR roadmap, alongside its diagnostics dominance, makes it a broad incumbent competing with JN Medsys in hospital and clinical-lab nucleic acid quantification workflows.

TypeBroad incumbent
Description

Revvity (formerly PerkinElmer) sells laboratory automation, qPCR/dPCR reagents, and diagnostic kits that overlap with JN Medsys's consumables, services, and clinical-validation offerings in research and clinical labs.

TypeDirect peer
Description

Standard BioTools (formerly Fluidigm) historically sold chip-based dPCR and single-cell genomics instrumentation that competes with JN Medsys's high-density chip partitioning approach, particularly in academic and translational research labs.

TypeRegional player
Description

DAAN Gene is a leading Chinese molecular diagnostics provider that is both a JN Medsys customer and a regional competitor in clinical PCR-based testing, IVD kits, and laboratory services across China and Southeast Asia.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JN Medsys

Digital PCR Instrumentationjnmedsys.com

JN Medsys is a Singapore-headquartered life science tools company that develops chip-based digital PCR instruments, consumables, assay kits, and laboratory services for absolute nucleic acid quantification, serving academic, clinical diagnostics, and industrial customers across Asia-Pacific via direct sales and eight regional distributors.

What JN Medsys does

JN Medsys is a privately held life science tools company headquartered in Singapore (with Beijing also cited as a founding location) that develops and commercializes a chip-based digital PCR (dPCR) platform under the Clarity product family. The company's core technology is a proprietary high-density chip-in-a-tube partitioning architecture that produces over 40,000 nanoliter partitions per reaction, combined with a 6-color CMOS detection platform that enables multiplexed absolute quantification of DNA and RNA without reference standards. The product ecosystem comprises the Clarity Plus Digital PCR System (Reader, Auto-Loader, Sealing Enhancer, software), the Exponent Thermal Cycler, chip-based consumables (40K and 10K tube-strips) that drive recurring revenue, and a portfolio of pre-formulated and custom assay kits.

JN Medsys monetizes through a hybrid model combining capital equipment sales, single-use consumables, assay kits, and fee-for-service laboratory offerings that include sample analysis, assay development, clinical validation via a Ministry of Health approved clinical laboratory, and NGS services. Go-to-market is executed through direct sales out of Singapore and a network of eight authorized regional distributors across China, Japan, South Korea, India, Taiwan, Vietnam, Indonesia, and Turkey, targeting research and academic institutions as well as clinical and diagnostics companies.

The company's differentiation rests on three pillars: a technically novel partitioning method that competes with Bio-Rad, Thermo Fisher, and Stilla on partition density and dynamic range; an AI-assisted analysis pipeline that automates positive/negative partition classification across tens of thousands of data points per run; and an explicit affordability positioning relative to incumbent dPCR platforms. Visible customers include the National University of Singapore, National Cheng Kung University, the Institute of Molecular and Cell Biology, Nippon Dental University, and DAAN GENE, and the company supports its commercial narrative through a library of peer-reviewed publications.

JN Medsys firmographics

Firmographics
Name
JN Medsys
Legal name
JN Medsys
Website
https://jnmedsys.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
JN Medsys is a Singapore-headquartered life science tools company that develops chip-based digital PCR instruments, consumables, assay kits, and laboratory services for absolute nucleic acid quantification, serving academic, clinical diagnostics, and industrial customers across Asia-Pacific via direct sales and eight regional distributors.
Ownership category
akta.pro rank

JN Medsys industry classification

Industry
Product category
Digital PCR Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)

Keywords

  • Digital PCR instruments
  • Nucleic acid quantification
  • Molecular biology instruments
  • Genomics research tools
  • PCR consumables

Where JN Medsys is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices1 record

Markets served

JN Medsys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Instruments and Hardware: Sale of Clarity Plus Digital PCR system, Clarity Auto-Loader, Clarity Sealing Enhancer, Clarity Plus Reader, and related instrument components.
  2. Consumables: Sale of proprietary chip-based consumables including 40K and 10K tube-strips, sample loading kits, and sealing fluid. Recurring revenue from consumables as they are single-use per experiment.
  3. Laboratory Services: Fee-for-service laboratory analysis including digital PCR sample analysis, qPCR services, assay development and validation, clinical validation (Ministry of Health approved clinical laboratory), and next-generation sequencing (NGS) services.
  4. Assay Kits: Sale of pre-developed and custom assay kits for specific molecular detection applications.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractClarity Plus Digital PCR System

Go-to-market motion1 record

Distribution channels9 records

Marketing channels5 records

JN Medsys product offering

Product offering

Core offering

JN Medsys designs, manufactures, and sells high-density chip-based digital PCR (dPCR) systems for absolute quantification of nucleic acids (DNA and RNA). Its flagship Clarity Plus Digital PCR System provides over 40,000 partitions per reaction with 6-colour multiplex detection, complemented by proprietary 40K and 10K chip-in-a-tube consumables, the Exponent Thermal Cycler, assay kits, and fee-for-service laboratory work including sample analysis, assay development, clinical validation, and next-generation sequencing.

Product overview

JN Medsys offers a comprehensive digital PCR ecosystem built around their proprietary high-density chip-based partitioning technology. The core offering consists of the Clarity Plus Digital PCR System (instrument with 6-color detection, up to 96 reactions, 40,000+ partitions per reaction), supported by dedicated Clarity Consumables (40K and 10K tube-strips with chip-in-a-tube design). The system is complemented by the Exponent Thermal Cycler and Assay Kits for complete workflow solutions. All components are designed to work together seamlessly, with automated sample loading via the Auto-Loader and AI-powered software for data analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • Clarity: Digital PCR system product line
  • Clarity Plus

Products and services

  • Clarity Plus Digital PCR System A cutting-edge digital PCR system featuring more than 40,000 partitions per reaction on a high-density chip, delivering high resolution, sensitivity, and dynamic range for RNA and DNA quantification. It includes a 6-colour detection platform for multiplexed quantification of up to 6 targets without reference standards, supports up to 96 reactions per run, and uses AI-powered software for absolute quantification. It is intended for research laboratories, clinical diagnostics developers, and applied testing organizations.
  • Clarity Consumables (40K and 10K Tube-Strips) Proprietary single-use chip-in-a-tube consumables for the Clarity / Clarity Plus digital PCR system, available in 40K (40,000-45,000 partitions, 0.3 nL per partition) and 10K (10,000 partitions, 1.3 nL per partition) formats. Each tube-strip holds 8 samples, and the chip design with excess capacity keeps sample loss below 5% while ensuring the entire sample volume is partitioned. Consumables generate recurring revenue for JN Medsys and are intended for any laboratory performing digital PCR experiments.
  • Exponent Thermal Cycler A thermal cycler compatible with the Clarity Plus digital PCR system, used to perform PCR amplification of partitioned samples as part of the Clarity workflow. Sold to research and clinical laboratories using the JN Medsys digital PCR platform.
  • Assay Kits Pre-formulated and custom assay kits for digital PCR applications, including in-house assays and assays developed against customer specifications for specific research or clinical detection needs. Sold to research and clinical laboratory customers using the Clarity digital PCR platform.
  • Sample Analysis Service Fee-for-service laboratory service in which JN Medsys receives customer samples and analyzes and quantifies them using in-house or customer-provided digital PCR and qPCR assays. Targeted at customers who need digital PCR data without running the workflow themselves.
  • Assay Development Service Custom assay development service for digital PCR and qPCR, including validation and on-request manufacturing for the customer. Targeted at research and clinical diagnostics customers needing tailored molecular detection assays.
  • Clinical Validation Service Clinical laboratory validation of customer diagnostic products for regulatory purposes, performed in JN Medsys' Ministry of Health-approved clinical laboratory. Targeted at diagnostics companies preparing products for regulatory submission.
  • Next Generation Sequencing (NGS) Service Next-generation sequencing service run by JN Medsys as an offering for customers who require sequencing in addition to or instead of digital PCR. Targeted at the same research and clinical customers served by the Clarity digital PCR system.

Quantifiable outcome

  • Over 40,000 partitions per reaction for single molecule analysis providing higher sensitivity and better accuracy over wider dynamic range
  • +2 more outcomes

Companies that use JN Medsys

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

JN Medsys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

JN Medsys partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered standard.

  • Hangzhou Neoline Technology Co., Ltd.standardChannel Partner/ Reseller/ DistributorAuthorized distributor for China market covering Hangzhou region with responsibility for sales, support, and distribution of JN Medsys digital PCR products.
  • Restar CorporationstandardChannel Partner/ Reseller/ DistributorAuthorized distributor for Japan market providing local sales and distribution of Clarity digital PCR systems and consumables.
  • BioD Co., Ltd.standardChannel Partner/ Reseller/ DistributorAuthorized distributor for South Korea market based in Gwangmyeong Technopark.
  • Premas Life Sciences Pvt LtdstandardChannel Partner/ Reseller/ DistributorAuthorized distributor for India market based in New Delhi, providing distribution of JN Medsys products.
  • EYS Medikal ve Lab. Pro.standardChannel Partner/ Reseller/ DistributorAuthorized distributor for Turkey market providing sales and distribution services.
  • Bestgen Biotech Corp.standardChannel Partner/ Reseller/ DistributorAuthorized distributor for Taiwan market based in New Taipei City.
  • Suran Medical & Scientific SolutionstandardChannel Partner/ Reseller/ DistributorAuthorized distributor for Vietnam market providing medical and scientific solutions.
  • AdvisainsstandardChannel Partner/ Reseller/ DistributorAuthorized distributor for Indonesia market based in Jakarta.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

JN Medsys competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad's QX200 and QX600 droplet digital PCR systems are the dominant installed-base competitor to JN Medsys's Clarity Plus, serving similar academic, clinical, and applied-market customers with chip-equivalent partitioning and multiplex workflows.
  • QIAGEN: QIAGEN's QIAcuity nanoplates-based dPCR platform competes head-to-head with Clarity Plus in research and clinical labs, offering higher-throughput plates, an IVD-cleared kitted assay menu, and global commercial reach that JN Medsys lacks.
  • Stilla Technologies: Stilla's Naica crystal digital PCR system uses similar chip-based partitioning and 6-color multiplex chemistry to Clarity Plus, targeting rare-mutation, liquid-biopsy, and oncology research customers across Europe and North America.
  • Standard BioTools: Standard BioTools (formerly Fluidigm) historically sold chip-based dPCR and single-cell genomics instrumentation that competes with JN Medsys's high-density chip partitioning approach, particularly in academic and translational research labs.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher's QuantStudio Absolute Q digital PCR system, sold alongside its broader qPCR, NGS, and clinical diagnostics portfolios, overlaps directly with JN Medsys's instrument and consumables offering while leveraging unmatched global service and support infrastructure.
  • Roche: Roche's LightCycler and digital PCR roadmap, alongside its diagnostics dominance, makes it a broad incumbent competing with JN Medsys in hospital and clinical-lab nucleic acid quantification workflows.
  • Revvity: Revvity (formerly PerkinElmer) sells laboratory automation, qPCR/dPCR reagents, and diagnostic kits that overlap with JN Medsys's consumables, services, and clinical-validation offerings in research and clinical labs.

Regional players

  • Da An Gene (DAAN Gene): DAAN Gene is a leading Chinese molecular diagnostics provider that is both a JN Medsys customer and a regional competitor in clinical PCR-based testing, IVD kits, and laboratory services across China and Southeast Asia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

JN Medsys social profiles

Digital presence

JN Medsys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JN Medsys leadership team

Management profile

Number of profiles

JN Medsys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JN Medsys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JN Medsys

What does JN Medsys do?

JN Medsys designs, manufactures, and sells high-density chip-based digital PCR (dPCR) systems for absolute quantification of nucleic acids (DNA and RNA). Its flagship Clarity Plus Digital PCR System provides over 40,000 partitions per reaction with 6-colour multiplex detection, complemented by proprietary 40K and 10K chip-in-a-tube consumables, the Exponent Thermal Cycler, assay kits, and fee-for-service laboratory work including sample analysis, assay development, clinical validation, and next-generation sequencing.

Is JN Medsys a public or private company?

JN Medsys is a private company. It is classified as unknown and is currently operating.

When was JN Medsys founded?

JN Medsys was founded in 2016. It employs 1 to 10 people.

Where is JN Medsys based?

JN Medsys is headquartered in Singapore, Singapore, in the Asia region.

How does JN Medsys make money?

Four revenue lines are on record. Instruments and Hardware is the primary driver. The others are consumables, laboratory Services and assay Kits.

Who are JN Medsys's main competitors?

Direct peers on record are Bio-Rad Laboratories, QIAGEN, Stilla Technologies and Standard BioTools. Broad incumbents are Thermo Fisher Scientific, Roche and Revvity. Da An Gene (DAAN Gene) is listed as a regional player.

Does JN Medsys have an API?

No public API is recorded for JN Medsys.

What industry is JN Medsys in?

JN Medsys's product category is Digital PCR Instrumentation. Its primary akta.pro industry code is HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals